Mitch Dowsett

Specialty: Breast Cancer Endocrine Therapy

Location: Unknown

Tier: ELITE

H-Index: 137

Years Active: 0

Hospital Affiliations

• Royal Marsden Hospital - Faculty

Key Publications

1. "20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years." - N Engl J Med (2017)
2. "Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group." - J Natl Cancer Inst (2021)
3. "Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer." - N Engl J Med (2005)
4. "11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial." - Lancet (2017)
5. "Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer." - Cancer Res (2016)

Knowledge Graph Relationships

Mitch Dowsett is a Breast Cancer Endocrine Therapy specialist affiliated with Royal Marsden Hospital. Authored 5 scholarly articles.